Versant Ventures IV LLC 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-14 5:06 pm Sale |
2024-03-21 | 13D | Adverum Biotechnologies, Inc. ADVM |
Versant Ventures IV LLC | 500,387 2.400% |
-2 (-0.00%) |
Filing |
| 2020-12-23 5:17 pm Sale |
2020-12-14 | 13D | Adverum Biotechnologies, Inc. ADVM |
Versant Ventures IV LLC | 500,389 5.100% |
-200,000 (-28.56%) |
Filing |